Wegovy® contains semaglutide and should not be utilized with other semaglutide-containing merchandise or other GLP-one receptor agonist medicines. Chance of thyroid cancer. Semaglutide, the active ingredient in Wegovy, elevated the potential risk of cancerous thyroid tumors in animal studies. It’s not identified no matter whether this threat can also be https://janes888mdu8.blogthisbiz.com/profile